trimetazidine has been researched along with dichloroacetic acid in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (18.18) | 18.2507 |
| 2000's | 7 (63.64) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bernard, M; Cozzone, P; El Banani, H; Feuvray, D; James, F | 1 |
| Bernard, M; Cozzone, PJ; el Banani, H; Feuvray, D | 1 |
| Barr, R; Dyck, JR; Lopaschuk, GD; Thomas, PD | 1 |
| Hill, JA; Schofield, RS | 1 |
| Pauly, DF; Pepine, CJ | 1 |
| Lopaschuk, GD | 1 |
| Celik, T; Iyisoy, A; Jata, B; Kursaklioglu, H | 1 |
| Marazzi, G; Rosano, GM; Volterrani, M | 1 |
| César, LA; Gowdak, LH; Mansur, AP | 1 |
| Beresewicz, A; Skierczynska, A | 1 |
| Heggermont, WA; Heymans, S; Papageorgiou, AP; van Bilsen, M | 1 |
4 review(s) available for trimetazidine and dichloroacetic acid
| Article | Year |
|---|---|
Role of metabolically active drugs in the management of ischemic heart disease.
Topics: Acetanilides; Animals; Cardiovascular Agents; Carnitine; Clinical Trials as Topic; Dichloroacetic Acid; Energy Metabolism; Fatty Acids; Glucose; Humans; Insulin; Myocardial Ischemia; Myocardium; Piperazines; Potassium; Ranolazine; Trimetazidine | 2001 |
Ischemic heart disease: metabolic approaches to management.
Topics: Acetanilides; Cardiovascular Agents; Carnitine; Dichloroacetic Acid; Energy Metabolism; Humans; Myocardial Ischemia; Oxidation-Reduction; Piperazines; Ranolazine; Ribose; Trimetazidine | 2004 |
The metabolic treatment of patients with coronary artery disease: effects on quality of life and effort angina.
Topics: Acetanilides; Angina Pectoris; Animals; Carnitine; Clinical Trials as Topic; Coronary Artery Disease; Dichloroacetic Acid; Humans; Piperazines; Quality of Life; Ranolazine; Ribose; Surveys and Questionnaires; Trimetazidine; Vasodilator Agents | 2009 |
Metabolic support for the heart: complementary therapy for heart failure?
Topics: Acetyl-CoA C-Acyltransferase; Cardiovascular Agents; Carnitine; Carnitine O-Palmitoyltransferase; Dichloroacetic Acid; Energy Metabolism; Enzyme Inhibitors; Epoxy Compounds; Fatty Acids; Glucose; Heart Failure; Humans; Myocardium; Myocytes, Cardiac; Oxidation-Reduction; Perhexiline; Ranolazine; Stroke Volume; Trimetazidine | 2016 |
7 other study(ies) available for trimetazidine and dichloroacetic acid
| Article | Year |
|---|---|
Ionic and metabolic imbalance as potential factors of ischemia reperfusion injury.
Topics: Acetylcarnitine; Animals; Dichloroacetic Acid; Disease Models, Animal; Energy Metabolism; Fatty Acids; Hydrogen-Ion Concentration; In Vitro Techniques; Intracellular Fluid; Lactic Acid; Magnetic Resonance Spectroscopy; Male; Myocardial Contraction; Myocardial Reperfusion Injury; Myocardium; Rats; Rats, Wistar; Trimetazidine; Vasodilator Agents; Ventricular Function, Left; Ventricular Pressure | 1998 |
Ionic and metabolic imbalance in various conditions of ischemia-reperfusion: a 31P- and 23Na-NMR study.
Topics: Animals; Anti-Arrhythmia Agents; Blood Pressure; Diastole; Dichloroacetic Acid; Enzyme Inhibitors; Guanidines; Heart; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Nuclear Magnetic Resonance, Biomolecular; Palmitic Acid; Phosphorus; Rats; Sodium; Sodium-Calcium Exchanger; Sodium-Hydrogen Exchangers; Sulfones; Trimetazidine; Vasodilator Agents | 1998 |
Beneficial effects of trimetazidine in ex vivo working ischemic hearts are due to a stimulation of glucose oxidation secondary to inhibition of long-chain 3-ketoacyl coenzyme a thiolase.
Topics: Acetyl-CoA C-Acyltransferase; Animals; Cardiotonic Agents; Dichloroacetic Acid; Dose-Response Relationship, Drug; Enzyme Activation; Fatty Acids; Glucose; Heart; In Vitro Techniques; Male; Myocardial Ischemia; Oxidation-Reduction; Rats; Rats, Sprague-Dawley; Recovery of Function; Trimetazidine; Vasodilator Agents | 2003 |
Optimizing cardiac fatty acid and glucose metabolism as an approach to treating heart failure.
Topics: Animals; Dichloroacetic Acid; Fatty Acids; Glucose; Heart Failure; Humans; Insulin; Myocardium; Trimetazidine | 2006 |
Metabolic agents in the management of diabetic coronary patients: a new era.
Topics: Carnitine; Coronary Disease; Diabetes Mellitus; Diabetic Angiopathies; Dichloroacetic Acid; Enzyme Inhibitors; Epoxy Compounds; Humans; Perhexiline; Trimetazidine; Vasodilator Agents; Vitamin B Complex | 2008 |
Metabolic agents in the management of diabetic coronary patients: a new era.
Topics: Acetanilides; Citric Acid Cycle; Coronary Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Dichloroacetic Acid; Enzyme Inhibitors; Epoxy Compounds; Humans; Insulin Resistance; Perhexiline; Piperazines; Ranolazine; Trimetazidine; Vasodilator Agents | 2008 |
Demand-induced ischemia in volume expanded isolated rat heart; the effect of dichloroacetate and trimetazidine.
Topics: Animals; Coronary Circulation; Dichloroacetic Acid; Disease Models, Animal; Dobutamine; Fatty Acids; Glucose; Glycolysis; Male; Myocardial Ischemia; Oxidation-Reduction; Oxygen Consumption; Palmitic Acid; Rats; Rats, Wistar; Trimetazidine | 2010 |